Infections in patients receiving immune checkpoint inhibitors.

Abstract Poster

Authors

null

Sutthichai Sae-Tia

Johns Hopkins University School of Medicine, Baltimore, MD

Sutthichai Sae-Tia, Jarushka Naidoo, Seema Mehta

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session B

Track

Breast and Gynecologic Cancers,Developmental Therapeutics,Genitourinary Cancer,Head and Neck Cancer,Lung Cancer,Melanoma/Skin Cancers,Gastrointestinal Cancer,Combination Studies,Implications for Patients and Society,Miscellaneous Cancers,Hematologic Malignancies

Sub Track

Immune Checkpoints and Stimulatory Receptors

Citation

J Clin Oncol 37, 2019 (suppl 8; abstr 155)

DOI

10.1200/JCO.2019.37.8_suppl.155

Abstract #

155

Poster Bd #

G9

Abstract Disclosures

Similar Posters

Poster

2018 Genitourinary Cancers Symposium

Immune-related adverse events (irAE) in GU cancer patients receiving immune checkpoint inhibitors.

Immune-related adverse events (irAE) in GU cancer patients receiving immune checkpoint inhibitors.

First Author: Peter Zang

First Author: Yukiko Shimoda Igawa

First Author: Evangelia Vlachou

First Author: Thierry Landre